Generic name:erenumab [ e-REN-ue-mab ]
Drug class:CGRP inhibitors
What is Aimovig?
Aimovig is a monoclonal antibody that blocks the activation of a certain protein that can produce a migraine attack. This protein, called calcitonin gene- related peptide (CGRP), can cause blood vessels to dilate and cause inflammation and migraine headache pain.
Aimovig is a prescription medicine used for the preventive treatment of migraine in adults.
Aimovig may also be used for purposes not listed in this medication guide.
Warnings
Before you inject Aimovig, always check the label of your single-dose prefilled autoinjector or single-dose prefilled syringe to make sure you have the correct medicine and the correct dose.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
You should not use Aimovig if you are allergic to erenumab.
Aimovig is not approved for use by anyone younger than 18 years old.
Tell your doctor if you have ever had:
an allergy to latex.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known whether erenumab will harm an unborn baby. However, having migraine headaches during pregnancy may cause complications such as preeclampsia (dangerously high blood pressure that can lead to medical problems in both mother and baby). The benefit of preventing migraines may outweigh any risks to the baby.
It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.
